Tina Thanner

10.06.2021 Munich / Paris / Frankfurt am Main ADVITOS GmbH (“ADVITOS”), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Crédit Mutuel Equity via its two subsidiaries Crédit Mutuel Equity Germany and Crédit Mutuel Innovation. In addition, ADVITOS received funding from the […]

14.05.2021 Munich – ADVITOS GmbH has been selected by the EIB Institute as one of the 15 best social entrepreneurs out of 280 applicants from 28 countries in Europe The European Investment Bank (EIB) Institute supports higher education and research and has launched the Social Innovation Tournament, which promotes innovative ideas and rewards initiatives that

24.11.2020 Munich – The Munich-based medical technology company was selected from 189 nominations by an independent jury and won the 1st main prize The Bavarian Innovation Award is a joint initiative of the Bavarian Ministry of Economic Affairs, the Association of Bavarian Chambers of Industry and Commerce and the Association of Bavarian Chambers of Trade.

30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic. In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies

30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic. In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies

01.06.2020 We mourn for our long-time colleague and friend Prof. Dr. Wolfgang Huber. Prof. Dr. Huber was an extraordinary personality and an outstanding doctor and researcher. During years of cooperation he was significantly involved in the development of the ADVOS therapy. Without him our therapy would not exist in this form today. Assoc. Prof. Dr.

24.04.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, a Munich based company, is currently being used in Intensive Care Units next to ventilators to save lives of people suffering from Covid-19. ADVITOS’s patented medical devices, unique in the world, can support

30.03.2020 Munich – ADVITOS paves the way to internationalization by recruiting Dr. Stephan Aldinger as the new Head of Sales & Marketing International. Stephan started his professional career as the co-founder and Member of the Executive Board of TERAKLIN, a medical device business which focused on implementing a new liver support therapy (MARS). The company

24.02.2020 Munich – ADVITOS announces the appointment of Dr. Philipp Stolka as new Head of Research and Development with immediate effect. Philipp joined the company in October 2019 as Deputy Head of Research and Development. Prior to this, Philipp was Chief Technology Officer and Chief Science Officer at Clear Guide Medical Inc., a medtech company

12.12.2019 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, prevails against 5 competitors at the Nordic Financial Ecosystem Forum and wins Best Investor Pitch Award The third Nordic Financial Ecosystem Forum in Brussels is co-hosted by Nasdaq, EQT and the Nordic Securities